nodes	percent_of_prediction	percent_of_DWPC	metapath
Dorzolamide—CYP3A4—prostate cancer	0.161	1	CbGaD
Dorzolamide—CYP3A4—Estradiol valerate/Dienogest—prostate cancer	0.054	0.126	CbGbCtD
Dorzolamide—CYP2C9—Bicalutamide—prostate cancer	0.0488	0.114	CbGbCtD
Dorzolamide—CYP2C9—Nilutamide—prostate cancer	0.0488	0.114	CbGbCtD
Dorzolamide—CYP2C9—Estrone—prostate cancer	0.0292	0.0685	CbGbCtD
Dorzolamide—CYP3A4—Bicalutamide—prostate cancer	0.0284	0.0664	CbGbCtD
Dorzolamide—CYP3A4—Estramustine—prostate cancer	0.0264	0.0618	CbGbCtD
Dorzolamide—CYP3A4—Abiraterone—prostate cancer	0.0235	0.0551	CbGbCtD
Dorzolamide—CYP3A4—Flutamide—prostate cancer	0.0235	0.0551	CbGbCtD
Dorzolamide—CYP2C9—Capecitabine—prostate cancer	0.0221	0.0519	CbGbCtD
Dorzolamide—CYP3A4—Cabazitaxel—prostate cancer	0.0174	0.0407	CbGbCtD
Dorzolamide—CYP3A4—Estrone—prostate cancer	0.017	0.0398	CbGbCtD
Dorzolamide—CYP2C9—Estradiol—prostate cancer	0.0168	0.0393	CbGbCtD
Dorzolamide—CYP3A4—Ethinyl Estradiol—prostate cancer	0.0151	0.0355	CbGbCtD
Dorzolamide—CYP3A4—Conjugated Estrogens—prostate cancer	0.0111	0.026	CbGbCtD
Dorzolamide—CYP3A4—Mitoxantrone—prostate cancer	0.0101	0.0237	CbGbCtD
Dorzolamide—CYP3A4—Estradiol—prostate cancer	0.00976	0.0229	CbGbCtD
Dorzolamide—CYP3A4—Prednisone—prostate cancer	0.00839	0.0197	CbGbCtD
Dorzolamide—CYP3A4—Etoposide—prostate cancer	0.00637	0.0149	CbGbCtD
Dorzolamide—CYP3A4—Docetaxel—prostate cancer	0.00583	0.0137	CbGbCtD
Dorzolamide—CYP3A4—Doxorubicin—prostate cancer	0.00435	0.0102	CbGbCtD
Dorzolamide—CA14—prostate gland—prostate cancer	0.00304	0.0826	CbGeAlD
Dorzolamide—CYP2C9—urine—prostate cancer	0.00286	0.0779	CbGeAlD
Dorzolamide—CA14—seminal vesicle—prostate cancer	0.00257	0.0698	CbGeAlD
Dorzolamide—CA7—renal system—prostate cancer	0.00248	0.0675	CbGeAlD
Dorzolamide—CYP3A4—urine—prostate cancer	0.00218	0.0594	CbGeAlD
Dorzolamide—CA5B—prostate gland—prostate cancer	0.00212	0.0578	CbGeAlD
Dorzolamide—CA12—renal system—prostate cancer	0.00161	0.0439	CbGeAlD
Dorzolamide—CA4—prostate gland—prostate cancer	0.00147	0.0399	CbGeAlD
Dorzolamide—CA5B—urethra—prostate cancer	0.00142	0.0387	CbGeAlD
Dorzolamide—CA9—testis—prostate cancer	0.00141	0.0383	CbGeAlD
Dorzolamide—CA1—renal system—prostate cancer	0.00128	0.0348	CbGeAlD
Dorzolamide—CA4—seminal vesicle—prostate cancer	0.00124	0.0337	CbGeAlD
Dorzolamide—CA2—prostate gland—prostate cancer	0.00122	0.0331	CbGeAlD
Dorzolamide—CA2—seminal vesicle—prostate cancer	0.00103	0.028	CbGeAlD
Dorzolamide—CA4—renal system—prostate cancer	0.000999	0.0272	CbGeAlD
Dorzolamide—CA4—urethra—prostate cancer	0.000982	0.0267	CbGeAlD
Dorzolamide—CA1—bone marrow—prostate cancer	0.000967	0.0263	CbGeAlD
Dorzolamide—CA5B—testis—prostate cancer	0.000936	0.0254	CbGeAlD
Dorzolamide—Brinzolamide—CYP3A4—prostate cancer	0.000927	1	CrCbGaD
Dorzolamide—CA2—epithelium—prostate cancer	0.000893	0.0243	CbGeAlD
Dorzolamide—CA2—renal system—prostate cancer	0.000829	0.0225	CbGeAlD
Dorzolamide—CA4—bone marrow—prostate cancer	0.000755	0.0205	CbGeAlD
Dorzolamide—CA5B—lymph node—prostate cancer	0.000678	0.0184	CbGeAlD
Dorzolamide—CA4—testis—prostate cancer	0.000646	0.0176	CbGeAlD
Dorzolamide—CA2—bone marrow—prostate cancer	0.000626	0.017	CbGeAlD
Dorzolamide—CA1—lymph node—prostate cancer	0.000599	0.0163	CbGeAlD
Dorzolamide—CA2—testis—prostate cancer	0.000536	0.0146	CbGeAlD
Dorzolamide—CYP3A4—renal system—prostate cancer	0.000535	0.0145	CbGeAlD
Dorzolamide—CA4—lymph node—prostate cancer	0.000468	0.0127	CbGeAlD
Dorzolamide—CA2—lymph node—prostate cancer	0.000388	0.0106	CbGeAlD
Dorzolamide—Hypertension—Capecitabine—prostate cancer	8.73e-05	0.000333	CcSEcCtD
Dorzolamide—Dry mouth—Docetaxel—prostate cancer	8.7e-05	0.000332	CcSEcCtD
Dorzolamide—Upper respiratory tract infection—Doxorubicin—prostate cancer	8.69e-05	0.000332	CcSEcCtD
Dorzolamide—Sweating—Epirubicin—prostate cancer	8.64e-05	0.00033	CcSEcCtD
Dorzolamide—Arthralgia—Capecitabine—prostate cancer	8.61e-05	0.000329	CcSEcCtD
Dorzolamide—Chest pain—Capecitabine—prostate cancer	8.61e-05	0.000329	CcSEcCtD
Dorzolamide—Confusional state—Docetaxel—prostate cancer	8.59e-05	0.000328	CcSEcCtD
Dorzolamide—Anxiety—Capecitabine—prostate cancer	8.58e-05	0.000327	CcSEcCtD
Dorzolamide—Anaphylactic shock—Docetaxel—prostate cancer	8.52e-05	0.000325	CcSEcCtD
Dorzolamide—Oedema—Docetaxel—prostate cancer	8.52e-05	0.000325	CcSEcCtD
Dorzolamide—Discomfort—Capecitabine—prostate cancer	8.51e-05	0.000325	CcSEcCtD
Dorzolamide—Epistaxis—Epirubicin—prostate cancer	8.5e-05	0.000325	CcSEcCtD
Dorzolamide—Vision blurred—Prednisone—prostate cancer	8.49e-05	0.000324	CcSEcCtD
Dorzolamide—Weight decreased—Doxorubicin—prostate cancer	8.46e-05	0.000323	CcSEcCtD
Dorzolamide—Sinusitis—Epirubicin—prostate cancer	8.46e-05	0.000323	CcSEcCtD
Dorzolamide—Feeling abnormal—Etoposide—prostate cancer	8.45e-05	0.000323	CcSEcCtD
Dorzolamide—Hyperglycaemia—Doxorubicin—prostate cancer	8.44e-05	0.000322	CcSEcCtD
Dorzolamide—Diarrhoea—Mitoxantrone—prostate cancer	8.44e-05	0.000322	CcSEcCtD
Dorzolamide—Dry mouth—Capecitabine—prostate cancer	8.42e-05	0.000321	CcSEcCtD
Dorzolamide—Vomiting—Estradiol—prostate cancer	8.41e-05	0.000321	CcSEcCtD
Dorzolamide—Agranulocytosis—Epirubicin—prostate cancer	8.41e-05	0.000321	CcSEcCtD
Dorzolamide—Gastrointestinal pain—Etoposide—prostate cancer	8.39e-05	0.00032	CcSEcCtD
Dorzolamide—Shock—Docetaxel—prostate cancer	8.39e-05	0.00032	CcSEcCtD
Dorzolamide—Rash—Estradiol—prostate cancer	8.34e-05	0.000318	CcSEcCtD
Dorzolamide—Dermatitis—Estradiol—prostate cancer	8.34e-05	0.000318	CcSEcCtD
Dorzolamide—Confusional state—Capecitabine—prostate cancer	8.32e-05	0.000318	CcSEcCtD
Dorzolamide—Headache—Estradiol—prostate cancer	8.29e-05	0.000316	CcSEcCtD
Dorzolamide—Stevens-Johnson syndrome—Doxorubicin—prostate cancer	8.27e-05	0.000316	CcSEcCtD
Dorzolamide—Oedema—Capecitabine—prostate cancer	8.25e-05	0.000315	CcSEcCtD
Dorzolamide—Bradycardia—Epirubicin—prostate cancer	8.24e-05	0.000314	CcSEcCtD
Dorzolamide—Angioedema—Prednisone—prostate cancer	8.23e-05	0.000314	CcSEcCtD
Dorzolamide—Urticaria—Etoposide—prostate cancer	8.15e-05	0.000311	CcSEcCtD
Dorzolamide—Anorexia—Docetaxel—prostate cancer	8.12e-05	0.00031	CcSEcCtD
Dorzolamide—Shock—Capecitabine—prostate cancer	8.12e-05	0.00031	CcSEcCtD
Dorzolamide—Abdominal pain—Etoposide—prostate cancer	8.11e-05	0.000309	CcSEcCtD
Dorzolamide—Body temperature increased—Etoposide—prostate cancer	8.11e-05	0.000309	CcSEcCtD
Dorzolamide—Conjunctivitis—Doxorubicin—prostate cancer	8.11e-05	0.000309	CcSEcCtD
Dorzolamide—Urinary tract infection—Doxorubicin—prostate cancer	8.11e-05	0.000309	CcSEcCtD
Dorzolamide—Vertigo—Prednisone—prostate cancer	8.09e-05	0.000309	CcSEcCtD
Dorzolamide—Syncope—Prednisone—prostate cancer	8.08e-05	0.000308	CcSEcCtD
Dorzolamide—Pharyngitis—Epirubicin—prostate cancer	8.03e-05	0.000307	CcSEcCtD
Dorzolamide—Sweating—Doxorubicin—prostate cancer	8e-05	0.000305	CcSEcCtD
Dorzolamide—Hyperhidrosis—Capecitabine—prostate cancer	7.98e-05	0.000304	CcSEcCtD
Dorzolamide—Hypotension—Docetaxel—prostate cancer	7.96e-05	0.000304	CcSEcCtD
Dorzolamide—Loss of consciousness—Prednisone—prostate cancer	7.92e-05	0.000302	CcSEcCtD
Dorzolamide—Epistaxis—Doxorubicin—prostate cancer	7.87e-05	0.0003	CcSEcCtD
Dorzolamide—Anorexia—Capecitabine—prostate cancer	7.87e-05	0.0003	CcSEcCtD
Dorzolamide—Nausea—Estradiol—prostate cancer	7.86e-05	0.0003	CcSEcCtD
Dorzolamide—Vomiting—Mitoxantrone—prostate cancer	7.84e-05	0.000299	CcSEcCtD
Dorzolamide—Sinusitis—Doxorubicin—prostate cancer	7.83e-05	0.000299	CcSEcCtD
Dorzolamide—Visual impairment—Epirubicin—prostate cancer	7.8e-05	0.000298	CcSEcCtD
Dorzolamide—Agranulocytosis—Doxorubicin—prostate cancer	7.78e-05	0.000297	CcSEcCtD
Dorzolamide—Hypertension—Prednisone—prostate cancer	7.78e-05	0.000297	CcSEcCtD
Dorzolamide—Rash—Mitoxantrone—prostate cancer	7.77e-05	0.000297	CcSEcCtD
Dorzolamide—Dermatitis—Mitoxantrone—prostate cancer	7.77e-05	0.000296	CcSEcCtD
Dorzolamide—Musculoskeletal discomfort—Docetaxel—prostate cancer	7.77e-05	0.000296	CcSEcCtD
Dorzolamide—Headache—Mitoxantrone—prostate cancer	7.72e-05	0.000295	CcSEcCtD
Dorzolamide—Hypotension—Capecitabine—prostate cancer	7.71e-05	0.000294	CcSEcCtD
Dorzolamide—Insomnia—Docetaxel—prostate cancer	7.71e-05	0.000294	CcSEcCtD
Dorzolamide—Arthralgia—Prednisone—prostate cancer	7.67e-05	0.000293	CcSEcCtD
Dorzolamide—Paraesthesia—Docetaxel—prostate cancer	7.65e-05	0.000292	CcSEcCtD
Dorzolamide—Erythema multiforme—Epirubicin—prostate cancer	7.65e-05	0.000292	CcSEcCtD
Dorzolamide—Anxiety—Prednisone—prostate cancer	7.64e-05	0.000292	CcSEcCtD
Dorzolamide—Bradycardia—Doxorubicin—prostate cancer	7.62e-05	0.000291	CcSEcCtD
Dorzolamide—Dyspnoea—Docetaxel—prostate cancer	7.6e-05	0.00029	CcSEcCtD
Dorzolamide—Somnolence—Docetaxel—prostate cancer	7.58e-05	0.000289	CcSEcCtD
Dorzolamide—Discomfort—Prednisone—prostate cancer	7.58e-05	0.000289	CcSEcCtD
Dorzolamide—Hypersensitivity—Etoposide—prostate cancer	7.56e-05	0.000288	CcSEcCtD
Dorzolamide—Tinnitus—Epirubicin—prostate cancer	7.54e-05	0.000288	CcSEcCtD
Dorzolamide—Musculoskeletal discomfort—Capecitabine—prostate cancer	7.52e-05	0.000287	CcSEcCtD
Dorzolamide—Dyspepsia—Docetaxel—prostate cancer	7.5e-05	0.000286	CcSEcCtD
Dorzolamide—Insomnia—Capecitabine—prostate cancer	7.46e-05	0.000285	CcSEcCtD
Dorzolamide—Pharyngitis—Doxorubicin—prostate cancer	7.43e-05	0.000284	CcSEcCtD
Dorzolamide—Paraesthesia—Capecitabine—prostate cancer	7.41e-05	0.000283	CcSEcCtD
Dorzolamide—Decreased appetite—Docetaxel—prostate cancer	7.41e-05	0.000283	CcSEcCtD
Dorzolamide—Asthenia—Etoposide—prostate cancer	7.36e-05	0.000281	CcSEcCtD
Dorzolamide—Dyspnoea—Capecitabine—prostate cancer	7.36e-05	0.000281	CcSEcCtD
Dorzolamide—Anaphylactic shock—Prednisone—prostate cancer	7.35e-05	0.000281	CcSEcCtD
Dorzolamide—Oedema—Prednisone—prostate cancer	7.35e-05	0.000281	CcSEcCtD
Dorzolamide—Fatigue—Docetaxel—prostate cancer	7.35e-05	0.00028	CcSEcCtD
Dorzolamide—Nausea—Mitoxantrone—prostate cancer	7.32e-05	0.00028	CcSEcCtD
Dorzolamide—Pain—Docetaxel—prostate cancer	7.29e-05	0.000278	CcSEcCtD
Dorzolamide—Dyspepsia—Capecitabine—prostate cancer	7.26e-05	0.000277	CcSEcCtD
Dorzolamide—Pruritus—Etoposide—prostate cancer	7.26e-05	0.000277	CcSEcCtD
Dorzolamide—Shock—Prednisone—prostate cancer	7.23e-05	0.000276	CcSEcCtD
Dorzolamide—Arrhythmia—Epirubicin—prostate cancer	7.23e-05	0.000276	CcSEcCtD
Dorzolamide—Visual impairment—Doxorubicin—prostate cancer	7.22e-05	0.000275	CcSEcCtD
Dorzolamide—Decreased appetite—Capecitabine—prostate cancer	7.17e-05	0.000274	CcSEcCtD
Dorzolamide—Alopecia—Epirubicin—prostate cancer	7.15e-05	0.000273	CcSEcCtD
Dorzolamide—Fatigue—Capecitabine—prostate cancer	7.11e-05	0.000272	CcSEcCtD
Dorzolamide—Hyperhidrosis—Prednisone—prostate cancer	7.11e-05	0.000271	CcSEcCtD
Dorzolamide—Erythema multiforme—Doxorubicin—prostate cancer	7.08e-05	0.00027	CcSEcCtD
Dorzolamide—Pain—Capecitabine—prostate cancer	7.06e-05	0.000269	CcSEcCtD
Dorzolamide—Erythema—Epirubicin—prostate cancer	7.04e-05	0.000269	CcSEcCtD
Dorzolamide—Feeling abnormal—Docetaxel—prostate cancer	7.02e-05	0.000268	CcSEcCtD
Dorzolamide—Diarrhoea—Etoposide—prostate cancer	7.02e-05	0.000268	CcSEcCtD
Dorzolamide—Anorexia—Prednisone—prostate cancer	7.01e-05	0.000267	CcSEcCtD
Dorzolamide—Tinnitus—Doxorubicin—prostate cancer	6.98e-05	0.000266	CcSEcCtD
Dorzolamide—Gastrointestinal pain—Docetaxel—prostate cancer	6.97e-05	0.000266	CcSEcCtD
Dorzolamide—Tension—Epirubicin—prostate cancer	6.91e-05	0.000264	CcSEcCtD
Dorzolamide—Dysgeusia—Epirubicin—prostate cancer	6.9e-05	0.000263	CcSEcCtD
Dorzolamide—Nervousness—Epirubicin—prostate cancer	6.84e-05	0.000261	CcSEcCtD
Dorzolamide—Back pain—Epirubicin—prostate cancer	6.81e-05	0.00026	CcSEcCtD
Dorzolamide—Feeling abnormal—Capecitabine—prostate cancer	6.8e-05	0.00026	CcSEcCtD
Dorzolamide—Dizziness—Etoposide—prostate cancer	6.78e-05	0.000259	CcSEcCtD
Dorzolamide—Gastrointestinal pain—Capecitabine—prostate cancer	6.75e-05	0.000258	CcSEcCtD
Dorzolamide—Body temperature increased—Docetaxel—prostate cancer	6.74e-05	0.000257	CcSEcCtD
Dorzolamide—Abdominal pain—Docetaxel—prostate cancer	6.74e-05	0.000257	CcSEcCtD
Dorzolamide—Musculoskeletal discomfort—Prednisone—prostate cancer	6.7e-05	0.000256	CcSEcCtD
Dorzolamide—Arrhythmia—Doxorubicin—prostate cancer	6.69e-05	0.000255	CcSEcCtD
Dorzolamide—Insomnia—Prednisone—prostate cancer	6.65e-05	0.000254	CcSEcCtD
Dorzolamide—Vision blurred—Epirubicin—prostate cancer	6.64e-05	0.000253	CcSEcCtD
Dorzolamide—Alopecia—Doxorubicin—prostate cancer	6.62e-05	0.000253	CcSEcCtD
Dorzolamide—Paraesthesia—Prednisone—prostate cancer	6.6e-05	0.000252	CcSEcCtD
Dorzolamide—Urticaria—Capecitabine—prostate cancer	6.56e-05	0.00025	CcSEcCtD
Dorzolamide—Body temperature increased—Capecitabine—prostate cancer	6.52e-05	0.000249	CcSEcCtD
Dorzolamide—Abdominal pain—Capecitabine—prostate cancer	6.52e-05	0.000249	CcSEcCtD
Dorzolamide—Vomiting—Etoposide—prostate cancer	6.52e-05	0.000249	CcSEcCtD
Dorzolamide—Erythema—Doxorubicin—prostate cancer	6.52e-05	0.000249	CcSEcCtD
Dorzolamide—Dyspepsia—Prednisone—prostate cancer	6.47e-05	0.000247	CcSEcCtD
Dorzolamide—Rash—Etoposide—prostate cancer	6.47e-05	0.000247	CcSEcCtD
Dorzolamide—Dermatitis—Etoposide—prostate cancer	6.46e-05	0.000247	CcSEcCtD
Dorzolamide—Headache—Etoposide—prostate cancer	6.43e-05	0.000245	CcSEcCtD
Dorzolamide—Tension—Doxorubicin—prostate cancer	6.4e-05	0.000244	CcSEcCtD
Dorzolamide—Decreased appetite—Prednisone—prostate cancer	6.39e-05	0.000244	CcSEcCtD
Dorzolamide—Dysgeusia—Doxorubicin—prostate cancer	6.38e-05	0.000244	CcSEcCtD
Dorzolamide—Fatigue—Prednisone—prostate cancer	6.34e-05	0.000242	CcSEcCtD
Dorzolamide—Nervousness—Doxorubicin—prostate cancer	6.33e-05	0.000242	CcSEcCtD
Dorzolamide—Vertigo—Epirubicin—prostate cancer	6.33e-05	0.000242	CcSEcCtD
Dorzolamide—Syncope—Epirubicin—prostate cancer	6.32e-05	0.000241	CcSEcCtD
Dorzolamide—Back pain—Doxorubicin—prostate cancer	6.3e-05	0.000241	CcSEcCtD
Dorzolamide—Hypersensitivity—Docetaxel—prostate cancer	6.28e-05	0.00024	CcSEcCtD
Dorzolamide—Palpitations—Epirubicin—prostate cancer	6.23e-05	0.000238	CcSEcCtD
Dorzolamide—Loss of consciousness—Epirubicin—prostate cancer	6.19e-05	0.000236	CcSEcCtD
Dorzolamide—Cough—Epirubicin—prostate cancer	6.15e-05	0.000235	CcSEcCtD
Dorzolamide—Vision blurred—Doxorubicin—prostate cancer	6.14e-05	0.000234	CcSEcCtD
Dorzolamide—Asthenia—Docetaxel—prostate cancer	6.12e-05	0.000233	CcSEcCtD
Dorzolamide—Nausea—Etoposide—prostate cancer	6.09e-05	0.000233	CcSEcCtD
Dorzolamide—Hypertension—Epirubicin—prostate cancer	6.08e-05	0.000232	CcSEcCtD
Dorzolamide—Hypersensitivity—Capecitabine—prostate cancer	6.08e-05	0.000232	CcSEcCtD
Dorzolamide—Feeling abnormal—Prednisone—prostate cancer	6.06e-05	0.000231	CcSEcCtD
Dorzolamide—Pruritus—Docetaxel—prostate cancer	6.03e-05	0.00023	CcSEcCtD
Dorzolamide—Gastrointestinal pain—Prednisone—prostate cancer	6.01e-05	0.000229	CcSEcCtD
Dorzolamide—Chest pain—Epirubicin—prostate cancer	6e-05	0.000229	CcSEcCtD
Dorzolamide—Arthralgia—Epirubicin—prostate cancer	6e-05	0.000229	CcSEcCtD
Dorzolamide—Anxiety—Epirubicin—prostate cancer	5.98e-05	0.000228	CcSEcCtD
Dorzolamide—Discomfort—Epirubicin—prostate cancer	5.93e-05	0.000226	CcSEcCtD
Dorzolamide—Asthenia—Capecitabine—prostate cancer	5.92e-05	0.000226	CcSEcCtD
Dorzolamide—Dry mouth—Epirubicin—prostate cancer	5.87e-05	0.000224	CcSEcCtD
Dorzolamide—Vertigo—Doxorubicin—prostate cancer	5.86e-05	0.000224	CcSEcCtD
Dorzolamide—Syncope—Doxorubicin—prostate cancer	5.85e-05	0.000223	CcSEcCtD
Dorzolamide—Urticaria—Prednisone—prostate cancer	5.84e-05	0.000223	CcSEcCtD
Dorzolamide—Pruritus—Capecitabine—prostate cancer	5.84e-05	0.000223	CcSEcCtD
Dorzolamide—Diarrhoea—Docetaxel—prostate cancer	5.83e-05	0.000223	CcSEcCtD
Dorzolamide—Abdominal pain—Prednisone—prostate cancer	5.81e-05	0.000222	CcSEcCtD
Dorzolamide—Body temperature increased—Prednisone—prostate cancer	5.81e-05	0.000222	CcSEcCtD
Dorzolamide—Confusional state—Epirubicin—prostate cancer	5.8e-05	0.000221	CcSEcCtD
Dorzolamide—Palpitations—Doxorubicin—prostate cancer	5.76e-05	0.00022	CcSEcCtD
Dorzolamide—Anaphylactic shock—Epirubicin—prostate cancer	5.75e-05	0.000219	CcSEcCtD
Dorzolamide—Oedema—Epirubicin—prostate cancer	5.75e-05	0.000219	CcSEcCtD
Dorzolamide—Loss of consciousness—Doxorubicin—prostate cancer	5.73e-05	0.000219	CcSEcCtD
Dorzolamide—Cough—Doxorubicin—prostate cancer	5.69e-05	0.000217	CcSEcCtD
Dorzolamide—Shock—Epirubicin—prostate cancer	5.66e-05	0.000216	CcSEcCtD
Dorzolamide—Diarrhoea—Capecitabine—prostate cancer	5.65e-05	0.000216	CcSEcCtD
Dorzolamide—Dizziness—Docetaxel—prostate cancer	5.64e-05	0.000215	CcSEcCtD
Dorzolamide—Hypertension—Doxorubicin—prostate cancer	5.63e-05	0.000215	CcSEcCtD
Dorzolamide—Hyperhidrosis—Epirubicin—prostate cancer	5.56e-05	0.000212	CcSEcCtD
Dorzolamide—Chest pain—Doxorubicin—prostate cancer	5.55e-05	0.000212	CcSEcCtD
Dorzolamide—Arthralgia—Doxorubicin—prostate cancer	5.55e-05	0.000212	CcSEcCtD
Dorzolamide—Anxiety—Doxorubicin—prostate cancer	5.53e-05	0.000211	CcSEcCtD
Dorzolamide—Discomfort—Doxorubicin—prostate cancer	5.48e-05	0.000209	CcSEcCtD
Dorzolamide—Anorexia—Epirubicin—prostate cancer	5.48e-05	0.000209	CcSEcCtD
Dorzolamide—Dizziness—Capecitabine—prostate cancer	5.46e-05	0.000208	CcSEcCtD
Dorzolamide—Dry mouth—Doxorubicin—prostate cancer	5.43e-05	0.000207	CcSEcCtD
Dorzolamide—Vomiting—Docetaxel—prostate cancer	5.42e-05	0.000207	CcSEcCtD
Dorzolamide—Hypersensitivity—Prednisone—prostate cancer	5.42e-05	0.000207	CcSEcCtD
Dorzolamide—Rash—Docetaxel—prostate cancer	5.37e-05	0.000205	CcSEcCtD
Dorzolamide—Hypotension—Epirubicin—prostate cancer	5.37e-05	0.000205	CcSEcCtD
Dorzolamide—Dermatitis—Docetaxel—prostate cancer	5.37e-05	0.000205	CcSEcCtD
Dorzolamide—Confusional state—Doxorubicin—prostate cancer	5.36e-05	0.000205	CcSEcCtD
Dorzolamide—Headache—Docetaxel—prostate cancer	5.34e-05	0.000204	CcSEcCtD
Dorzolamide—Anaphylactic shock—Doxorubicin—prostate cancer	5.32e-05	0.000203	CcSEcCtD
Dorzolamide—Oedema—Doxorubicin—prostate cancer	5.32e-05	0.000203	CcSEcCtD
Dorzolamide—Asthenia—Prednisone—prostate cancer	5.27e-05	0.000201	CcSEcCtD
Dorzolamide—Vomiting—Capecitabine—prostate cancer	5.25e-05	0.0002	CcSEcCtD
Dorzolamide—Musculoskeletal discomfort—Epirubicin—prostate cancer	5.24e-05	0.0002	CcSEcCtD
Dorzolamide—Shock—Doxorubicin—prostate cancer	5.23e-05	0.0002	CcSEcCtD
Dorzolamide—Rash—Capecitabine—prostate cancer	5.2e-05	0.000199	CcSEcCtD
Dorzolamide—Pruritus—Prednisone—prostate cancer	5.2e-05	0.000199	CcSEcCtD
Dorzolamide—Insomnia—Epirubicin—prostate cancer	5.2e-05	0.000198	CcSEcCtD
Dorzolamide—Dermatitis—Capecitabine—prostate cancer	5.2e-05	0.000198	CcSEcCtD
Dorzolamide—Headache—Capecitabine—prostate cancer	5.17e-05	0.000197	CcSEcCtD
Dorzolamide—Paraesthesia—Epirubicin—prostate cancer	5.16e-05	0.000197	CcSEcCtD
Dorzolamide—Hyperhidrosis—Doxorubicin—prostate cancer	5.14e-05	0.000196	CcSEcCtD
Dorzolamide—Dyspnoea—Epirubicin—prostate cancer	5.13e-05	0.000196	CcSEcCtD
Dorzolamide—Somnolence—Epirubicin—prostate cancer	5.11e-05	0.000195	CcSEcCtD
Dorzolamide—Anorexia—Doxorubicin—prostate cancer	5.07e-05	0.000194	CcSEcCtD
Dorzolamide—Nausea—Docetaxel—prostate cancer	5.06e-05	0.000193	CcSEcCtD
Dorzolamide—Dyspepsia—Epirubicin—prostate cancer	5.06e-05	0.000193	CcSEcCtD
Dorzolamide—Diarrhoea—Prednisone—prostate cancer	5.03e-05	0.000192	CcSEcCtD
Dorzolamide—Decreased appetite—Epirubicin—prostate cancer	5e-05	0.000191	CcSEcCtD
Dorzolamide—Hypotension—Doxorubicin—prostate cancer	4.97e-05	0.00019	CcSEcCtD
Dorzolamide—Fatigue—Epirubicin—prostate cancer	4.96e-05	0.000189	CcSEcCtD
Dorzolamide—Pain—Epirubicin—prostate cancer	4.92e-05	0.000188	CcSEcCtD
Dorzolamide—Nausea—Capecitabine—prostate cancer	4.9e-05	0.000187	CcSEcCtD
Dorzolamide—Dizziness—Prednisone—prostate cancer	4.86e-05	0.000186	CcSEcCtD
Dorzolamide—Musculoskeletal discomfort—Doxorubicin—prostate cancer	4.85e-05	0.000185	CcSEcCtD
Dorzolamide—Insomnia—Doxorubicin—prostate cancer	4.81e-05	0.000184	CcSEcCtD
Dorzolamide—Paraesthesia—Doxorubicin—prostate cancer	4.78e-05	0.000182	CcSEcCtD
Dorzolamide—Dyspnoea—Doxorubicin—prostate cancer	4.74e-05	0.000181	CcSEcCtD
Dorzolamide—Feeling abnormal—Epirubicin—prostate cancer	4.74e-05	0.000181	CcSEcCtD
Dorzolamide—Somnolence—Doxorubicin—prostate cancer	4.73e-05	0.00018	CcSEcCtD
Dorzolamide—Gastrointestinal pain—Epirubicin—prostate cancer	4.7e-05	0.000179	CcSEcCtD
Dorzolamide—Dyspepsia—Doxorubicin—prostate cancer	4.68e-05	0.000179	CcSEcCtD
Dorzolamide—Vomiting—Prednisone—prostate cancer	4.67e-05	0.000178	CcSEcCtD
Dorzolamide—Rash—Prednisone—prostate cancer	4.63e-05	0.000177	CcSEcCtD
Dorzolamide—Dermatitis—Prednisone—prostate cancer	4.63e-05	0.000177	CcSEcCtD
Dorzolamide—Decreased appetite—Doxorubicin—prostate cancer	4.62e-05	0.000176	CcSEcCtD
Dorzolamide—Headache—Prednisone—prostate cancer	4.61e-05	0.000176	CcSEcCtD
Dorzolamide—Fatigue—Doxorubicin—prostate cancer	4.59e-05	0.000175	CcSEcCtD
Dorzolamide—Urticaria—Epirubicin—prostate cancer	4.57e-05	0.000174	CcSEcCtD
Dorzolamide—Pain—Doxorubicin—prostate cancer	4.55e-05	0.000174	CcSEcCtD
Dorzolamide—Abdominal pain—Epirubicin—prostate cancer	4.54e-05	0.000173	CcSEcCtD
Dorzolamide—Body temperature increased—Epirubicin—prostate cancer	4.54e-05	0.000173	CcSEcCtD
Dorzolamide—Feeling abnormal—Doxorubicin—prostate cancer	4.38e-05	0.000167	CcSEcCtD
Dorzolamide—Nausea—Prednisone—prostate cancer	4.37e-05	0.000167	CcSEcCtD
Dorzolamide—Gastrointestinal pain—Doxorubicin—prostate cancer	4.35e-05	0.000166	CcSEcCtD
Dorzolamide—Hypersensitivity—Epirubicin—prostate cancer	4.24e-05	0.000162	CcSEcCtD
Dorzolamide—Urticaria—Doxorubicin—prostate cancer	4.23e-05	0.000161	CcSEcCtD
Dorzolamide—Abdominal pain—Doxorubicin—prostate cancer	4.21e-05	0.000161	CcSEcCtD
Dorzolamide—Body temperature increased—Doxorubicin—prostate cancer	4.21e-05	0.000161	CcSEcCtD
Dorzolamide—Asthenia—Epirubicin—prostate cancer	4.12e-05	0.000157	CcSEcCtD
Dorzolamide—Pruritus—Epirubicin—prostate cancer	4.07e-05	0.000155	CcSEcCtD
Dorzolamide—Diarrhoea—Epirubicin—prostate cancer	3.93e-05	0.00015	CcSEcCtD
Dorzolamide—Hypersensitivity—Doxorubicin—prostate cancer	3.92e-05	0.00015	CcSEcCtD
Dorzolamide—Asthenia—Doxorubicin—prostate cancer	3.82e-05	0.000146	CcSEcCtD
Dorzolamide—Dizziness—Epirubicin—prostate cancer	3.8e-05	0.000145	CcSEcCtD
Dorzolamide—Pruritus—Doxorubicin—prostate cancer	3.76e-05	0.000144	CcSEcCtD
Dorzolamide—Vomiting—Epirubicin—prostate cancer	3.66e-05	0.00014	CcSEcCtD
Dorzolamide—Diarrhoea—Doxorubicin—prostate cancer	3.64e-05	0.000139	CcSEcCtD
Dorzolamide—Rash—Epirubicin—prostate cancer	3.62e-05	0.000138	CcSEcCtD
Dorzolamide—Dermatitis—Epirubicin—prostate cancer	3.62e-05	0.000138	CcSEcCtD
Dorzolamide—Headache—Epirubicin—prostate cancer	3.6e-05	0.000137	CcSEcCtD
Dorzolamide—Dizziness—Doxorubicin—prostate cancer	3.52e-05	0.000134	CcSEcCtD
Dorzolamide—Nausea—Epirubicin—prostate cancer	3.41e-05	0.00013	CcSEcCtD
Dorzolamide—Vomiting—Doxorubicin—prostate cancer	3.38e-05	0.000129	CcSEcCtD
Dorzolamide—Rash—Doxorubicin—prostate cancer	3.35e-05	0.000128	CcSEcCtD
Dorzolamide—Dermatitis—Doxorubicin—prostate cancer	3.35e-05	0.000128	CcSEcCtD
Dorzolamide—Headache—Doxorubicin—prostate cancer	3.33e-05	0.000127	CcSEcCtD
Dorzolamide—Nausea—Doxorubicin—prostate cancer	3.16e-05	0.000121	CcSEcCtD
Dorzolamide—CA4—Metabolism—PIK3CD—prostate cancer	1.4e-05	0.000124	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—B4GALT4—prostate cancer	1.39e-05	0.000123	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—HPGD—prostate cancer	1.39e-05	0.000123	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—INS—prostate cancer	1.38e-05	0.000123	CbGpPWpGaD
Dorzolamide—CA5B—Metabolism—EP300—prostate cancer	1.36e-05	0.000121	CbGpPWpGaD
Dorzolamide—CA7—Metabolism—EP300—prostate cancer	1.36e-05	0.000121	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—CREBBP—prostate cancer	1.36e-05	0.00012	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—PIK3CD—prostate cancer	1.34e-05	0.000119	CbGpPWpGaD
Dorzolamide—CA12—Metabolism—PTEN—prostate cancer	1.32e-05	0.000117	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—NOS3—prostate cancer	1.32e-05	0.000117	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—TNFRSF21—prostate cancer	1.31e-05	0.000116	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—CSAD—prostate cancer	1.3e-05	0.000115	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—GRHL1—prostate cancer	1.3e-05	0.000115	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—TST—prostate cancer	1.3e-05	0.000115	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—CBR1—prostate cancer	1.3e-05	0.000115	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—ADI1—prostate cancer	1.3e-05	0.000115	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—PSAT1—prostate cancer	1.3e-05	0.000115	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—PIK3CG—prostate cancer	1.29e-05	0.000114	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—PIK3CD—prostate cancer	1.29e-05	0.000114	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—CYP7B1—prostate cancer	1.27e-05	0.000113	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—MTAP—prostate cancer	1.27e-05	0.000113	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—NOS3—prostate cancer	1.27e-05	0.000112	CbGpPWpGaD
Dorzolamide—CA12—Metabolism—EP300—prostate cancer	1.26e-05	0.000112	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—prostate cancer	1.24e-05	0.00011	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—SULT1E1—prostate cancer	1.24e-05	0.00011	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—SRD5A1—prostate cancer	1.24e-05	0.00011	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—PIK3CB—prostate cancer	1.22e-05	0.000108	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—INS—prostate cancer	1.22e-05	0.000108	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—NOS3—prostate cancer	1.21e-05	0.000108	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—CKMT2—prostate cancer	1.21e-05	0.000107	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—GRHPR—prostate cancer	1.21e-05	0.000107	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—UGT2B17—prostate cancer	1.21e-05	0.000107	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—UGT2B15—prostate cancer	1.21e-05	0.000107	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—PTGS2—prostate cancer	1.21e-05	0.000107	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—GGT1—prostate cancer	1.2e-05	0.000107	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—CREBBP—prostate cancer	1.19e-05	0.000106	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—NCOA1—prostate cancer	1.18e-05	0.000105	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—ACSL4—prostate cancer	1.18e-05	0.000105	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—HSD17B3—prostate cancer	1.18e-05	0.000105	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—PIK3CB—prostate cancer	1.17e-05	0.000104	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—prostate cancer	1.17e-05	0.000104	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—PTGS2—prostate cancer	1.16e-05	0.000103	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—GSTM3—prostate cancer	1.14e-05	0.000101	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—AOX1—prostate cancer	1.14e-05	0.000101	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—SULT2B1—prostate cancer	1.14e-05	0.000101	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—MBTPS1—prostate cancer	1.14e-05	0.000101	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—PGAM2—prostate cancer	1.14e-05	0.000101	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—NAGLU—prostate cancer	1.14e-05	0.000101	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—RFK—prostate cancer	1.14e-05	0.000101	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—PHGDH—prostate cancer	1.13e-05	0.0001	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—ARG2—prostate cancer	1.13e-05	0.0001	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—UMPS—prostate cancer	1.13e-05	0.0001	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—PIK3CD—prostate cancer	1.13e-05	0.0001	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—RXRA—prostate cancer	1.13e-05	9.99e-05	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—PIK3CB—prostate cancer	1.12e-05	9.94e-05	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—PTGS2—prostate cancer	1.11e-05	9.85e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—LDHB—prostate cancer	1.11e-05	9.85e-05	CbGpPWpGaD
Dorzolamide—CA14—Metabolism—PIK3CA—prostate cancer	1.11e-05	9.81e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—CYP3A5—prostate cancer	1.09e-05	9.67e-05	CbGpPWpGaD
Dorzolamide—CA5A—Metabolism—PIK3CA—prostate cancer	1.08e-05	9.56e-05	CbGpPWpGaD
Dorzolamide—CA6—Metabolism—PIK3CA—prostate cancer	1.08e-05	9.56e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—CYP3A43—prostate cancer	1.08e-05	9.56e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—AMACR—prostate cancer	1.08e-05	9.56e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—SRD5A2—prostate cancer	1.08e-05	9.56e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—DEGS1—prostate cancer	1.08e-05	9.56e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—NAT1—prostate cancer	1.08e-05	9.56e-05	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—NOS3—prostate cancer	1.07e-05	9.47e-05	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—PTEN—prostate cancer	1.05e-05	9.35e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—GSTA3—prostate cancer	1.05e-05	9.34e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—TCN2—prostate cancer	1.05e-05	9.34e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—PDHA1—prostate cancer	1.05e-05	9.34e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—UCP3—prostate cancer	1.05e-05	9.34e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—HSD17B1—prostate cancer	1.03e-05	9.12e-05	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—PTEN—prostate cancer	1.01e-05	8.96e-05	CbGpPWpGaD
Dorzolamide—CA5B—Metabolism—PIK3CA—prostate cancer	1.01e-05	8.92e-05	CbGpPWpGaD
Dorzolamide—CA7—Metabolism—PIK3CA—prostate cancer	1.01e-05	8.92e-05	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—EP300—prostate cancer	1e-05	8.91e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—HSD3B1—prostate cancer	1e-05	8.91e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—SLC22A3—prostate cancer	1e-05	8.91e-05	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—PIK3CB—prostate cancer	9.85e-06	8.74e-05	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—PTGS2—prostate cancer	9.76e-06	8.66e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—LPL—prostate cancer	9.74e-06	8.64e-05	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—PTEN—prostate cancer	9.69e-06	8.59e-05	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—EP300—prostate cancer	9.63e-06	8.54e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—GSTA4—prostate cancer	9.63e-06	8.54e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—TBXAS1—prostate cancer	9.63e-06	8.54e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—prostate cancer	9.41e-06	8.35e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—GSTA2—prostate cancer	9.38e-06	8.32e-05	CbGpPWpGaD
Dorzolamide—CA12—Metabolism—PIK3CA—prostate cancer	9.32e-06	8.27e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—SULT1A1—prostate cancer	9.27e-06	8.22e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—ABCG5—prostate cancer	9.27e-06	8.22e-05	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—EP300—prostate cancer	9.24e-06	8.19e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—B4GALT4—prostate cancer	9.16e-06	8.12e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—HPGD—prostate cancer	9.16e-06	8.12e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—GSTA1—prostate cancer	9.05e-06	8.03e-05	CbGpPWpGaD
Dorzolamide—CA14—Metabolism—AKT1—prostate cancer	9.04e-06	8.01e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—GSTO1—prostate cancer	8.95e-06	7.94e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—HSD3B2—prostate cancer	8.95e-06	7.94e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—NAT2—prostate cancer	8.95e-06	7.94e-05	CbGpPWpGaD
Dorzolamide—CA6—Metabolism—AKT1—prostate cancer	8.81e-06	7.81e-05	CbGpPWpGaD
Dorzolamide—CA5A—Metabolism—AKT1—prostate cancer	8.81e-06	7.81e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—TNFRSF21—prostate cancer	8.61e-06	7.64e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—prostate cancer	8.61e-06	7.63e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—CYP2C18—prostate cancer	8.58e-06	7.61e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—PLCB2—prostate cancer	8.58e-06	7.61e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—LRP2—prostate cancer	8.58e-06	7.61e-05	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—PTEN—prostate cancer	8.51e-06	7.55e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—P4HB—prostate cancer	8.42e-06	7.46e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—CYP7B1—prostate cancer	8.38e-06	7.43e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—MTAP—prostate cancer	8.38e-06	7.43e-05	CbGpPWpGaD
Dorzolamide—CA7—Metabolism—AKT1—prostate cancer	8.22e-06	7.29e-05	CbGpPWpGaD
Dorzolamide—CA5B—Metabolism—AKT1—prostate cancer	8.22e-06	7.29e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—SLC22A1—prostate cancer	8.19e-06	7.26e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—SRD5A1—prostate cancer	8.17e-06	7.24e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—SULT1E1—prostate cancer	8.17e-06	7.24e-05	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—EP300—prostate cancer	8.12e-06	7.2e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—prostate cancer	8.09e-06	7.18e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—SULT2A1—prostate cancer	7.98e-06	7.08e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—MED12—prostate cancer	7.85e-06	6.96e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—ACSL4—prostate cancer	7.79e-06	6.91e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—HSD17B3—prostate cancer	7.79e-06	6.91e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—GNG5—prostate cancer	7.79e-06	6.91e-05	CbGpPWpGaD
Dorzolamide—CA12—Metabolism—AKT1—prostate cancer	7.62e-06	6.75e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—NCOA3—prostate cancer	7.5e-06	6.65e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—UMPS—prostate cancer	7.47e-06	6.62e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—PHGDH—prostate cancer	7.47e-06	6.62e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—ARG2—prostate cancer	7.47e-06	6.62e-05	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—PIK3CA—prostate cancer	7.43e-06	6.59e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—prostate cancer	7.37e-06	6.54e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—LDHB—prostate cancer	7.32e-06	6.5e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—CYP3A5—prostate cancer	7.19e-06	6.38e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—HPGDS—prostate cancer	7.16e-06	6.35e-05	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—PIK3CA—prostate cancer	7.13e-06	6.32e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—CYP2C19—prostate cancer	7.11e-06	6.31e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—PDHA1—prostate cancer	6.94e-06	6.16e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—TCN2—prostate cancer	6.94e-06	6.16e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—GSTA3—prostate cancer	6.94e-06	6.16e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—UCP3—prostate cancer	6.94e-06	6.16e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—GSTT1—prostate cancer	6.94e-06	6.16e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—ACHE—prostate cancer	6.94e-06	6.16e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—CYP2A6—prostate cancer	6.86e-06	6.08e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	6.83e-06	6.06e-05	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—PIK3CA—prostate cancer	6.83e-06	6.06e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—AKR1C3—prostate cancer	6.67e-06	5.92e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—PRKACB—prostate cancer	6.64e-06	5.89e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—SLC22A3—prostate cancer	6.62e-06	5.87e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—HSD3B1—prostate cancer	6.62e-06	5.87e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—CYP17A1—prostate cancer	6.57e-06	5.83e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	6.48e-06	5.75e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—TBXAS1—prostate cancer	6.35e-06	5.63e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—GSTA4—prostate cancer	6.35e-06	5.63e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—NCOA2—prostate cancer	6.26e-06	5.55e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—GSTA2—prostate cancer	6.19e-06	5.49e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—SULT1A1—prostate cancer	6.11e-06	5.42e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—ABCG5—prostate cancer	6.11e-06	5.42e-05	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—AKT1—prostate cancer	6.07e-06	5.39e-05	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—PIK3CA—prostate cancer	6.01e-06	5.33e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—SLC5A5—prostate cancer	5.97e-06	5.3e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—GSTA1—prostate cancer	5.97e-06	5.29e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—GSTO1—prostate cancer	5.9e-06	5.24e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—HSD3B2—prostate cancer	5.9e-06	5.24e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—NAT2—prostate cancer	5.9e-06	5.24e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—CYP2E1—prostate cancer	5.83e-06	5.17e-05	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—AKT1—prostate cancer	5.82e-06	5.16e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—NQO1—prostate cancer	5.77e-06	5.12e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—TH—prostate cancer	5.68e-06	5.04e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—PLCB2—prostate cancer	5.66e-06	5.02e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—CYP2C18—prostate cancer	5.66e-06	5.02e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—LRP2—prostate cancer	5.66e-06	5.02e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	5.65e-06	5.01e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—CYP3A4—prostate cancer	5.62e-06	4.99e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	5.6e-06	4.96e-05	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—AKT1—prostate cancer	5.58e-06	4.95e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—P4HB—prostate cancer	5.55e-06	4.92e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—CYP1B1—prostate cancer	5.53e-06	4.9e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—SLC22A1—prostate cancer	5.4e-06	4.79e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—GGT1—prostate cancer	5.36e-06	4.75e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—NCOA1—prostate cancer	5.28e-06	4.68e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—SULT2A1—prostate cancer	5.26e-06	4.67e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—CYP19A1—prostate cancer	5.2e-06	4.61e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—MED12—prostate cancer	5.18e-06	4.59e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—GNG5—prostate cancer	5.14e-06	4.55e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—RXRA—prostate cancer	5.02e-06	4.45e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—NCOA3—prostate cancer	4.95e-06	4.39e-05	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—AKT1—prostate cancer	4.91e-06	4.35e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	4.88e-06	4.33e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—COMT—prostate cancer	4.83e-06	4.29e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—GSTP1—prostate cancer	4.81e-06	4.27e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—ITPR1—prostate cancer	4.73e-06	4.2e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—HPGDS—prostate cancer	4.72e-06	4.19e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—CYP2C19—prostate cancer	4.69e-06	4.16e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—EP300—prostate cancer	4.65e-06	4.13e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—ACHE—prostate cancer	4.58e-06	4.06e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—GSTT1—prostate cancer	4.58e-06	4.06e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—CYP2A6—prostate cancer	4.52e-06	4.01e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—TYMS—prostate cancer	4.47e-06	3.97e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—GSTM1—prostate cancer	4.42e-06	3.92e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—AKR1C3—prostate cancer	4.4e-06	3.9e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—PRKACB—prostate cancer	4.38e-06	3.88e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—LPL—prostate cancer	4.34e-06	3.85e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—CYP17A1—prostate cancer	4.33e-06	3.84e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—CYP1A1—prostate cancer	4.19e-06	3.72e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—ERCC2—prostate cancer	4.16e-06	3.69e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—NCOA2—prostate cancer	4.13e-06	3.66e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—SLC5A5—prostate cancer	3.94e-06	3.49e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—MTHFR—prostate cancer	3.91e-06	3.47e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—CYP2E1—prostate cancer	3.85e-06	3.41e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—PPARA—prostate cancer	3.83e-06	3.4e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—NQO1—prostate cancer	3.8e-06	3.37e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—TH—prostate cancer	3.75e-06	3.33e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—CYP1B1—prostate cancer	3.65e-06	3.23e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—CAV1—prostate cancer	3.6e-06	3.2e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—GGT1—prostate cancer	3.53e-06	3.13e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—NCOA1—prostate cancer	3.48e-06	3.09e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	3.44e-06	3.05e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—CYP19A1—prostate cancer	3.43e-06	3.04e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—RXRA—prostate cancer	3.31e-06	2.93e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—PIK3CG—prostate cancer	3.28e-06	2.91e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—COMT—prostate cancer	3.19e-06	2.83e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—GSTP1—prostate cancer	3.17e-06	2.81e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—ITPR1—prostate cancer	3.12e-06	2.77e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—INS—prostate cancer	3.11e-06	2.76e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—CREBBP—prostate cancer	3.04e-06	2.7e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—TYMS—prostate cancer	2.95e-06	2.62e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—GSTM1—prostate cancer	2.92e-06	2.59e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—PIK3CD—prostate cancer	2.89e-06	2.56e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—LPL—prostate cancer	2.86e-06	2.54e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—CYP1A1—prostate cancer	2.76e-06	2.45e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—ERCC2—prostate cancer	2.74e-06	2.43e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—NOS3—prostate cancer	2.72e-06	2.42e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—MTHFR—prostate cancer	2.58e-06	2.29e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—PPARA—prostate cancer	2.53e-06	2.24e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—PIK3CB—prostate cancer	2.52e-06	2.23e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—PTGS2—prostate cancer	2.49e-06	2.21e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—CAV1—prostate cancer	2.38e-06	2.11e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—PTEN—prostate cancer	2.17e-06	1.93e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—PIK3CG—prostate cancer	2.16e-06	1.92e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—EP300—prostate cancer	2.07e-06	1.84e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—INS—prostate cancer	2.05e-06	1.82e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—CREBBP—prostate cancer	2.01e-06	1.78e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—PIK3CD—prostate cancer	1.9e-06	1.69e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—NOS3—prostate cancer	1.8e-06	1.59e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—PIK3CB—prostate cancer	1.66e-06	1.47e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—PTGS2—prostate cancer	1.64e-06	1.46e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—PIK3CA—prostate cancer	1.53e-06	1.36e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—PTEN—prostate cancer	1.43e-06	1.27e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—EP300—prostate cancer	1.37e-06	1.21e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—AKT1—prostate cancer	1.25e-06	1.11e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—PIK3CA—prostate cancer	1.01e-06	8.97e-06	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—AKT1—prostate cancer	8.26e-07	7.33e-06	CbGpPWpGaD
